Tarsus Pharmaceuticals, Inc. short interest in 2024
In 2024, Tarsus Pharmaceuticals, Inc.'s disclosed short interest ran from 15.15% of shares outstanding on 12 Jan 2024 to 19.17% on 31 Dec 2024, a change of +4.02 percentage points. The year's high was 26.16% on 30 Sep 2024 and its low 15.15% on 12 Jan 2024, averaging 21.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.60 days on 15 Oct 2024. Full history: Tarsus Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 15.15% (12 Jan 2024)
- End of year
- 19.17% (31 Dec 2024)
- Change
- +4.02 pp
- High
- 26.16% (30 Sep 2024)
- Low
- 15.15% (12 Jan 2024)
- Average
- 21.53%
- Highest days to cover
- 19.60 (15 Oct 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 15.15% | 7.94 | |
| 31 Jan 2024 | 16.40% | 6.90 | |
| 15 Feb 2024 | 17.11% | 7.62 | |
| 29 Feb 2024 | 18.22% | 5.26 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 21.74% | 8.62 | |
| 28 Mar 2024 | 23.71% | 16.12 | |
| 15 Apr 2024 | 23.86% | 12.51 | |
| 30 Apr 2024 | 23.14% | 19.48 | |
| 15 May 2024 | 19.78% | 10.06 | 10-Q filed, results (8-K) |
| 31 May 2024 | 19.79% | 17.28 | |
| 14 Jun 2024 | 21.08% | 13.47 | |
| 28 Jun 2024 | 22.39% | 8.70 | |
| 15 Jul 2024 | 23.31% | 14.30 | |
| 31 Jul 2024 | 25.83% | 13.34 | |
| 15 Aug 2024 | 25.08% | 9.32 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 25.75% | 17.93 | |
| 13 Sep 2024 | 24.96% | 11.83 | |
| 30 Sep 2024 | 26.16% | 17.58 | |
| 15 Oct 2024 | 25.44% | 19.60 | |
| 31 Oct 2024 | 21.44% | 8.75 | |
| 15 Nov 2024 | 18.68% | 6.68 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 18.78% | 14.57 | |
| 13 Dec 2024 | 19.73% | 14.89 | |
| 31 Dec 2024 | 19.17% | 14.07 |
See also: Tarsus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.